NCT04217525
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Drug Category: Other
Key Eligibility Criteria:
Gender: All
Age: 18 Years to 85 Years (Adult, Older Adult)
Location of Metastases: Bone
Additional Notes: Breast cancer patients must have metastatic tumors of the spine
Exclusions:
https://ClinicalTrials.gov/show/NCT04217525